Millendo Therapeutics' Series C Round

Millendo Therapeutics raised a round of funding on December 28, 2017.

Millendo Therapeutics, previously known as Atterocor, is a drug development company focused on a novel treatment for adrenal cancer. The company is accelerating the development of a new adrenal-target…

Articles about Millendo Therapeutics' Series C Round: